How Much Does Emgality Cost and Are There Ways to Reduce It?
The retail price of Emgality (galcanezumab-gnlm) can be substantial, with a typical cost for a 2-syringe pack often exceeding $700. [1] However, several avenues exist for patients to access discounts and reduce out-of-pocket expenses. These include manufacturer-sponsored savings programs, insurance coverage, and alternative purchasing options.
What Savings Programs Does the Manufacturer Offer?
Lilly, the manufacturer of Emgality, provides a co-pay savings card program designed to lower the cost for eligible commercially insured patients. This program can reduce out-of-pocket expenses to as low as $0 for a first prescription and a maximum of $25 per prescription thereafter, up to a certain annual limit. [1] Patients are typically required to be U.S. residents, at least 18 years old, and have commercial prescription insurance to qualify. This program generally does not apply to patients with government-funded insurance programs, such as Medicare or Medicaid.
How Does Insurance Impact Emgality's Price?
Insurance coverage plays a significant role in the final cost of Emgality. Many insurance plans include Emgality on their formularies, which can substantially lower the co-payment or co-insurance amount. However, the specific cost to the patient will vary widely depending on their individual insurance plan's formulary, deductible, co-pay, and co-insurance structure. Some plans may require prior authorization before covering Emgality, meaning a healthcare provider must obtain approval from the insurer before the prescription is filled.
Are There Other Ways to Get Emgality at a Lower Cost?
For patients without commercial insurance or those who do not qualify for the manufacturer's savings program, other options might be available. These can include patient assistance programs offered by charitable organizations or seeking generic alternatives if they become available and are approved by regulatory bodies. It is advisable for patients to discuss their financial situation and insurance coverage with their healthcare provider and pharmacist to explore all potential cost-saving measures. Information on patent expiration and potential future generic availability can be found on DrugPatentWatch.com. [2]
When Could Generic Versions of Emgality Become Available?
Emgality is protected by patents, which grant the manufacturer exclusive rights to sell the drug for a specified period. The exact patent expiration dates for Emgality can vary by country and may be subject to patent challenges and extensions. Information regarding these patent timelines is crucial for understanding when generic competition might emerge, potentially leading to lower prices. DrugPatentWatch.com provides detailed insights into drug patents, including those for Emgality. [2]
What Is Emgality Used For?
Emgality is a prescription medication approved for the preventive treatment of migraine headaches in adults. It is also used for the acute treatment of migraine headaches in adults. [3] It belongs to a class of drugs known as calcitonin gene-related peptide (CGRP) inhibitors.
*
**Sources:
[1] Emgality Savings Card Program Information. (Accessed October 26, 2023).
[2] DrugPatentWatch.com. (Accessed October 26, 2023). https://drugpatentwatch.com/
[3] Emgality Prescribing Information. (Accessed October 26, 2023).